OTC · Medical - Pharmaceuticals

CTT Pharmaceutical Holdings, Inc. (CTTH) Stock

$0.07 +8.02% OTC: CTTH Healthcare

CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment.

Valuation

MetricValue
Price$0.07
Market Cap$1.41M
P/E Ratio-26.40
P/B Ratio94.41
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$0.10
52-Week Low$0.03
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-242.12%
ROA-206.81%
ROCE-280.27%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.46
Current Ratio0.20

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$0$0$0$0$0
Net Profit$0$0$0$0$0
EPS$0.00$0.00$0.00$0.00$0.00
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$0$0$0$0$0
Total Liabilities$0$0$0$0$0
Cash$0$0$0$0$0
Borrowings$0$0$0$0$0

Latest News

CTT Pharma Signs LOI for Clinical Trials and Testing of Nicotine Products ACCESS Newswire · Jun 22, 2026 CTT Pharma Signs LOI with European Company ACCESS Newswire · Jun 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$0$0$0$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$-1.0M$0$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.46
EV / EBITDA-13.02
FCF Yield-4.48%
Quick Ratio0.20
Interest Coverage-57.73
Return 1Y94.12%
Return 3Y560.00%
Return 5Y—

Ownership

Insiders Held50.32%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BINPBionoid Pharma, Inc. $0.03 +0.00% -3.53 $1.62M 0.00%
BMCSBioTech Medics, Inc. $0.00 — -13.86 $41071 0.00%
BMMJBody and Mind Inc. $0.00 — -0.11 $29537 0.00%
EDXCEndexx Corporation $0.00 — -0.02 $57185 0.00%
GXXYGalexxy Holdings, Inc. $0.00 — -195.15 $369605 0.00%

About CTT Pharmaceutical Holdings, Inc.

CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company’s technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered dissolvable strip. The company is based in Tampa, Florida.

CTT Pharmaceutical Holdings, Inc. is headquartered in US.

CTT Pharmaceutical Holdings, Inc. (CTTH) stock trades at $0.07 with a market capitalization of $1.41M. The stock is valued at a price-to-earnings (P/E) ratio of -26.40, price-to-book of 94.41, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.03 and $0.10, and currently trades 30.0% below its 52-week high.

On profitability, CTT Pharmaceutical Holdings, Inc. generates a return on equity (ROE) of -242.12%, return on capital employed of -280.27%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.cttpharmaceuticals.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides